Avatar

Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maintenance Approaches

By Nina Shah 3 Videos
August 2017
0 Comments
Login to view comments. Click here to Login

Featured Video

10:17
Amgen Oncology

Multiple Myeloma: Use of Proteasome Inhibitor at First Relapse-A Case Study

Feat. H. Kaya

Featured Video

10:17
Amgen Oncology

Multiple Myeloma: Use of Proteasome Inhibitor at First Relapse-A Case Study

Feat. H. Kaya

Related Content

AUTOPLAY
Roswell Park Comprehensive Cancer Center

Plasma Cell Disorders Meeting 2019

Fri, Nov 1, 2019
International Society of Geriatric Oncology

19th Conference of the International Society of Geriatric Oncology

Thu, Nov 14, 2019
10:37
Amgen Oncology

Multiple Myeloma: Importance of Proteasome Inhibition at First Relapse

Feat. J. Abbas
25:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases

MM - Overview of Trials Presented at ASH 2018

Feat. A. Abdallah
17:58
Parameswaran Hari

Delivering the Best Initial Treatment for Myeloma: Induction Therapy and...

08:15
2018 Pan Pacific Lymphoma Conference

Evolution of Myeloma Induction Regimens

Feat. S. Holstein
08:40
Surbhi Sidana

Duration of Complete Response Impacts Overall Survival in Multiple Myeloma

06:12
Indy Hematology Review

Targeting Mutations in Myeloma with Venetoclax and Development of the Fi...

Feat. K. Anderson
10:30
Society of Hematologic Oncology Sixth Annual Meeting

Next Questions in Myeloma: Biology, Smoldering Myeloma, High-risk, MRD, ...

Feat. S. Jagannath
15:02
Krina Patel

Clinical Trials in Myeloma in 2018

19:41
Peter Voorhees

Approach to the Patient with Refractory & Multiple Relapsed Multiple Mye...

10:17
Amgen Oncology

Multiple Myeloma: Use of Proteasome Inhibitor at First Relapse-A Case Study

Feat. H. Kaya
15:11
Ajay Nooka

Early Relapse: Choosing Among Different Second Line Regimens in Myeloma

13:26
Shaji Kumar

Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma

16:22
Society of Hematologic Oncology Sixth Annual Meeting

FDA Approves Selinexor for Refractory Multiple Myeloma, STORM Study

Feat. S. Jagannath
12:32
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson
15:10
Krina Patel

Developing CAR T-cells in Multiple Myeloma

15:47
Society of Hematologic Oncology Sixth Annual Meeting

Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...

Feat. S. Lonial
09:01
Maria-Victoria Mateos

FDA Approves Once-Weekly Carfilzomib Regimen for Myeloma

15:31
Parameswaran Hari

Refractory and Relapsing Myeloma - When to Treat and Options Available

14:43
Society of Hematologic Oncology Sixth Annual Meeting

What Will The Future Hold for Myeloma Treatment CARTs vs BiTES?

Feat. R. Orlowski
17:58
City of Hope

Should Everyone Receive Monoclonal Antibodies at First Myeloma Relapse? No!

Feat. J. Mikhael